Dr. Rachel Brem decided to pursue a career in medicine at the age of 12 after her mother was diagnosed with breast cancer. Her mother’s extended survival beyond a six-month prognosis due to early detection motivated Brem to improve breast cancer screening methods. Dr. Brem is a board-certified radiologist and director of Breast Imaging and Intervention at George Washington University. She founded the Brem Foundation to combat breast cancer through prevention and early detection.
Impact of Artificial Intelligence on Breast Cancer Detection
Brem highlighted the transformative effect of AI in medicine, particularly in breast cancer detection. She collaborates with ScreenPoint Medical to develop Transpara, an AI software that enhances breast cancer screening. Studies show that mammograms accompanied by AI evaluations can identify cancer up to five years earlier by detecting signs often missed by mammograms alone. Additionally, AI can predict future breast cancer risk even when mammograms appear normal.
If women begin screening with AI technology at 35, the software continuously learns and improves its detection capabilities. Brem points out that this is earlier than many major organizations recommend, but vital for accurate early detection.
At George Washington University, AI has been integrated into mammograms for over four years without extra costs. Nationwide, however, only 20% of practices use AI in their procedures, and often at additional expense, potentially limiting access.
Addressing Inequalities with AI
Breast cancer cannot be entirely prevented, but Brem believes AI can help bridge racial disparities in detection and treatment. Black women have a 40% higher mortality rate from breast cancer compared to White women. Also, those with limited resources have reduced access to mammograms. Brem’s foundation focuses on early detection through innovative screening, education, and equitable access.
She is optimistic about broader AI adoption to improve cancer detection and healthcare delivery.
Innovative Screening: Breast Cancer Breath Test
Brem is involved in developing a noninvasive breath test that may detect breast cancer. Diseased tissues emit specific chemical compounds that, when converted into gas, can signal the need for further screening. While this test is not yet available, Brem envisions a future without painful or intrusive diagnostic methods. She aims to extend this innovation to a comprehensive women’s health panel, enabling multiple screenings from a single breath test.
The Current State of Breast Cancer Screening
The 2026 guidelines from the American College of Physicians recommend mammograms every other year for women over 50. The United States Preventive Services Task Force suggests starting at age 40. Brem considers these guidelines inadequate, advocating for annual screenings starting at 40 and even earlier for those with a family history of breast cancer.
Anxiety may cause women to delay screenings, yet early detection ensures significantly better outcomes. Early-stage breast cancer has a 99% survival rate, emphasizing the importance of regular screenings.
Emphasizing the Need for Supplementary Exams
For women with dense breasts, where mammograms might miss tumors, additional screenings such as ultrasounds, MRIs, or enhanced mammograms are crucial. However, these are not always standard practice. Brem stresses that women should advocate for these supplementary exams with their doctors, as regular mammograms alone may not suffice.
Empowering Women Through Education and Advocacy
Brem encourages women to be proactive in monitoring their health. Those with dense breasts should insist on additional screenings. She warns that breast cancer can occur at a younger age, and early conversations about a screening plan are vital. Education is key, and her foundation offers resources to inform women about their health risks.
Brem strongly urges women to be assertive in healthcare settings. “Be badass,” she declares. Women should advocate for their health needs, as it is their right and necessity to do so.
